Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,180.55
1,268.32
1,343.77
932.64
760.35
735.07
693.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,180.55
1,268.32
1,343.77
932.64
760.35
735.07
693.63
Raw Material Cost
449.07
473.44
500.44
344.04
236.85
317.57
309.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
205.48
255.38
268.66
141.93
86.04
0.00
0.00
Selling and Distribution Expenses
50.18
51.30
44.12
32.39
42.44
34.07
31.26
Other Expenses
38.09
45.18
48.08
33.56
22.55
31.37
30.28
Total Expenditure (Excl Depreciation)
1,085.61
1,231.90
1,293.96
853.91
590.80
665.34
643.80
Operating Profit (PBDIT) excl Other Income
94.9
36.4
49.800000000000004
78.7
169.60000000000002
69.7
49.800000000000004
Other Income
228.14
122.50
91.69
267.33
39.21
11.50
2.57
Operating Profit (PBDIT)
887.04
834.06
872.21
799.14
512.60
385.06
342.79
Interest
205.48
255.38
268.66
141.93
86.04
0.00
0.00
Exceptional Items
-367.08
-567.44
-154.92
-163.44
-22.94
-27.73
-21.65
Gross Profit (PBDT)
167.50
119.72
112.62
135.52
219.67
113.67
93.55
Depreciation
563.97
675.15
730.71
453.08
303.83
303.83
290.38
Profit Before Tax
-249.49
-663.90
-282.08
40.69
99.78
53.51
30.76
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-248.29
-660.40
-281.62
38.46
98.02
52.62
30.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-248.29
-660.40
-281.62
38.46
98.02
52.62
30.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.41
-9.42
-3.82
-0.20
1.77
0.89
0.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-251.70
-669.82
-285.44
38.26
99.78
53.51
30.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
4,616.89
5,234.86
6,822.66
7,571.08
3,257.60
3,174.24
3,358.01
Earnings per share (EPS)
-0.71
-1.81
-0.74
0.15
0.44
0.24
0.14
Diluted Earnings per share
-0.71
-1.81
-0.74
0.15
0.44
0.24
0.14
Operating Profit Margin (Excl OI)
8.04%
2.87%
3.71%
8.44%
22.3%
9.49%
7.18%
Gross Profit Margin
26.64%
0.89%
33.39%
52.94%
53.08%
48.61%
46.3%
PAT Margin
-21.03%
-52.07%
-20.96%
4.12%
12.89%
7.16%
4.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -6.92% vs -5.62% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 62.42% vs -134.69% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -7.41% vs -8.83% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -19.54% vs -4.95% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Healthcare Realty Trust, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
1,180.55
1,880.18
-699.63
-37.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,180.55
1,880.18
-699.63
-37.21%
Raw Material Cost
449.07
202.41
246.66
121.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
205.48
1,276.99
-1,071.51
-83.91%
Selling and Distribution Expenses
50.18
208.81
-158.63
-75.97%
Other Expenses
38.09
-124.08
162.17
130.70%
Total Expenditure (Excl Depreciation)
1,085.61
447.40
638.21
142.65%
Operating Profit (PBDIT) excl Other Income
94.94
1,432.78
-1,337.84
-93.37%
Other Income
228.14
306.34
-78.20
-25.53%
Operating Profit (PBDIT)
887.04
1,840.54
-953.50
-51.81%
Interest
205.48
1,276.99
-1,071.51
-83.91%
Exceptional Items
-367.08
17.68
-384.76
-2,176.24%
Gross Profit (PBDT)
167.50
1,595.71
-1,428.21
-89.50%
Depreciation
563.97
82.06
481.91
587.27%
Profit Before Tax
-249.49
479.81
-729.30
-152.00%
Tax
0.00
36.72
-36.72
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-248.29
402.36
-650.65
-161.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-248.29
402.36
-650.65
-161.71%
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.41
31.55
-34.96
-110.81%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-251.70
433.90
-685.60
-158.01%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
4,616.89
6,795.52
-2,178.63
-32.06%
Earnings per share (EPS)
-0.71
1.15
-1.86
-161.74%
Diluted Earnings per share
-0.71
1.15
-1.86
-161.74%
Operating Profit Margin (Excl OI)
8.04%
76.20%
0.00
-68.16%
Gross Profit Margin
26.64%
29.88%
0.00
-3.24%
PAT Margin
-21.03%
21.40%
0.00
-42.43%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 118.05 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -6.92% vs -5.62% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -25.17 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 62.42% vs -134.69% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.89 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -7.41% vs -8.83% in Dec 2024
Annual - Interest
Interest 20.55 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -19.54% vs -4.95% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.04%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
